Vext Science, Inc.
VEXT
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 50.68M | 51.97M | 51.37M | 47.83M | 44.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.68M | 51.97M | 51.37M | 47.83M | 44.15M |
| Cost of Revenue | 31.15M | 34.27M | 36.91M | 34.58M | 30.89M |
| Gross Profit | 19.54M | 17.70M | 14.45M | 13.26M | 13.26M |
| SG&A Expenses | 18.39M | 17.65M | 16.57M | 15.55M | 15.52M |
| Depreciation & Amortization | 4.68M | 4.85M | 4.72M | 4.57M | 4.43M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.22M | 56.77M | 58.20M | 54.70M | 50.84M |
| Operating Income | -3.54M | -4.80M | -6.83M | -6.86M | -6.69M |
| Income Before Tax | -12.63M | -12.30M | -15.22M | -13.36M | -13.22M |
| Income Tax Expenses | 1.76M | 3.25M | 2.78M | 3.30M | 3.30M |
| Earnings from Continuing Operations | -14.39 | -15.56 | -18.00 | -16.66 | -16.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.39M | -15.56M | -18.00M | -16.66M | -16.52M |
| EBIT | -3.54M | -4.80M | -6.83M | -6.86M | -6.69M |
| EBITDA | 11.50M | 10.58M | 8.57M | 8.39M | 8.42M |
| EPS Basic | -0.06 | -0.06 | -0.07 | -0.07 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.06 | -0.06 | -0.07 | -0.07 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 990.67M | 990.57M | 990.37M | 990.13M | 988.07M |
| Average Diluted Shares Outstanding | 990.67M | 990.57M | 990.37M | 990.13M | 991.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |